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Supplementary Issue: Cardiovascular Imaging: Current Developments in Research and Clinical Practice

Abstract
Background: Arterial calcium as measured by 64-slice computed tomography coronary angiography (64-CT) is a reliable predictor of cardiovascular
disease risk. Lipid-rich plaques with lower degrees of calcification may pose greater risk for adverse coronary events than more stabilized calcified plaques as
a result of the increased risk of plaque rupture, migration, and subsequent acute coronary syndrome. We sought to examine coronary artery calcium scores
as measured via 64-CT to assess the extent of calcification and plaque distribution in women compared to men.
Methods: A total of 138 patients referred for 64-CT were evaluated. Computerized tomographic angiography was performed using the GE LightSpeed
VCT. Subgroup analysis comparing male and female data (including demographic data) was performed. All major coronary arteries were analyzed for coronary
stenosis/plaque characterization as well as total vessel calcium (Agatston) score quantification. Patient demographics and coronary risk factors were recorded.
Results: A total of 552 coronary arteries were evaluated in 138 patients (85 men, 53 women). The average age for females was 64.4 ± 10.8 years and for
males 60.0 ± 12.8 years. The only demographic/cardiovascular risk factor in which the difference between men and women was significant was smoking history, where 23.5% of men had a history of smoking while only 9.6% of females endorsed having a smoking history (P , 0.044). On comparison of all total
vessel calcium scores, males had a higher total mean calcium score than females in each individual vessel. The results were as follows for males versus females,
respectively: left main total vessel calcium score 46.49 versus 16.71 (P = 0.167); left anterior descending 265.21 versus 109.6 (P , 0.003); left circumflex
130.5 versus 39.7 (P , 0.004); and right coronary 213.5 versus 73.8 (P , 0.01). The odds of having a total calcium score .100 (versus not) was 3.62 times
greater in males relative to females, given that all the other cardiovascular risk factors are adjusted for (95% confidence interval: 1.37–9.54). On average, men
had an average of 2.1 ± 1.5 epicardial vessels with a calcium score $11 compared to 1.3 ± 1.4 for women (P , 0.005).
Conclusion: There are clear differences between males and females regarding total vessel calcium scores and therefore risk of future adverse coronary
events. Males tended to have higher average calcium scores in each coronary artery than females with a greater tendency to have multiple vessel involvement.
Using this information, more large-scale, randomized controlled studies should be performed to correlate differences in the extent of coronary calcification
with the observed variance in clinical presentation during coronary events between males and females as a means to potentially establish gender-specific
therapeutic regimens.
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Introduction

The etiology of and pathophysiology surrounding the longaccepted and studied female gender advantage in coronary
heart disease (CHD) remains poorly understood. Numerous
studies have characterized the significant gender differences
with regards to the incidence and rate of development of atherosclerosis and the resulting morbidity and mortality associated with almost any degree of vascular compromise. Despite
numerous studies quantifying and attempting to explain the
female advantage in the development of CHD, the explanation for this advantage remains elusive. Differences between
men and women in the presentation, diagnosis, assessment, as

well as prognosis of cardiovascular disease are evident and have
prompted a worldwide campaign to redefine cardiovascular
disease as a female as well as male disease and to structure
treatment guidelines specifically for women.
Recent population data in the United States indicates that
despite an aging population and the obesity epidemic currently
plaguing the country, the mortality associated with CHD has
decreased in women from one in three to one in four.1 This
is likely at least partially a result of an increasing focus on
cardiac disease as not only a male disease. In fact, while often
underappreciated, cardiovascular disease is the leading cause
of death in women, far exceeding cancer and infectious causes.
Clinical Medicine Insights: Cardiology 2014:8(S4)
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Along with the increasing focus on cardiovascular disease as
a cause of significant morbidity and mortality in women have
come increasing observational studies and case series delineating the significant differences in almost every aspect of cardiac
disease between males and females. While large, randomized
controlled studies in the past focused on cardiovascular disease
primarily in male subjects, recent large-scale cardiac trials in
women have prompted the development of evidence-based
guidelines for CHD diagnosis and management in women.
The development of new means of noninvasive cardiac
imaging, particularly cardiac computerized tomographic
angiography (CTA; 64-CT) allows more extensive analysis of
the presence and nature of intra-arterial plaques. The presence and degree of intracoronary calcification has been shown
to correlate with the degree of atherosclerosis.1 The utility
of CTA in predicting risk of adverse cardiovascular disease
events has been demonstrated in numerous studies. Few studies, however, have utilized this relatively new technology
to shed light upon the significant gender differences in the
long-term development of intra-arterial plaques. CTA allows
for the description, both quantitatively and qualitatively, of a
lesion’s area, peak density, and mean density, enabling commentary regarding the composition (calcified as opposed to
lipid-laden, for example) of each intra-arterial lesion. Given
the long-acknowledged disparity between males and females
when it comes to cardiac disease, more studies are acknowledging these differences and attempting to explain the observed
variations. This has led to more stringent recommendations
regarding the approach to treatment of cardiac disease, particularly in postmenopausal women where there has been significant debate regarding the utility (or lack thereof) of hormone
replacement therapy and the use of vitamins and antioxidants.
In order to attempt to further investigate the observed differences between genders, we sought to use cardiac CT (Agatston method of quantification), 2 which has revolutionized the
noninvasive visualization and quantification of intracoronary
plaque burden over the past decade, to compare the pattern
and incidence of disease in males and females. A more extensive understanding of differences in the development, severity,
and distribution of coronary disease in males and females may
shed light on a still elusive subject.

Methods

Data collected from 138 consecutive patients referred for
64-CT at our institution was evaluated. CTA was performed
using the General Electric LightSpeed VCT (GE Healthcare).
Data were analyzed in a retrospective fashion after the institutional review board granted an exemption from the requirement for approval. The exemption was granted as the research
involved study of existing, de-identified data. Subgroup analysis comparing male and female data was performed. The four
major coronary arteries were analyzed for the presence of calcified coronary stenosis/plaque as according to the total vessel
calcium (Agatston) score quantification. Vessels analyzed were
52
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the left main (LM) coronary artery, the left anterior descending (LAD), the left circumflex (LCX), and the right coronary
artery (RCA). Patient demographics and coronary risk factors
including diabetes mellitus, hypertension, smoking history,
and dyslipidemia were recorded.
In order to be included in the study, patients must have
been at least 18 years of age. Patients underwent 64-slice
CT coronary angiography using the GE LightSpeed VCT.
Patients on whom no background information (demographic
data, medical history/risk factors) was recorded in the CTA
database were excluded from data analysis.
Statistical analysis. Based on the scores on calcium scoring of the LM, LAD, LCX, and RCA, the number of vessels
with a calcium score .11 and the number of vessels with lesions
101–400 were categorized. These two variables were also analyzed to determine if they were associated with gender using
the Fisher’s exact test. A result was considered to be statistically significant when two-tailed P was ,0.05. Patients were
classified into two groups: with “significant” disease or without
“significant” disease. A subject was classified as having significant disease if his/her total calcium score exceeds 100 HU (as
described above). Univariable comparisons of continuous variables were carried out using either the t-test or Mann–Whitney
test, as appropriate; for categorical variables, either the chisquare test or Fisher’s exact test was used, as appropriate.
Logistic regression analysis was carried out with “significant disease” as the “event” of interest using the following
explanatory variables in the model: gender, age, body mass
index (BMI), smoking status, hypertension, hypercholesterolemia and diabetes, as well as the interaction effects of gender and each of diabetes and smoking (gender × diabetes and
gender × smoking interaction).
In order to arrive at a more parsimonious model, a backward selection algorithm was applied in order to determine
which factors were most significantly associated with significant disease. Adjusted odds ratios are presented along with the
corresponding 95% confidence intervals. All analyses were generated using SAS 9.3 (SAS Institute Inc., Cary, NC, USA).

Results

A total of 552 coronary arteries were evaluated in 138 patients
(85 men, 53 women). Baseline demographic and risk factor
data is presented in Table 1. The average age for males was
60.0 ± 12.8 years and for the females, 64.4 ± 10.8 years. Males
had an average BMI of 29.5 ± 5.2 kg/m 2 while for females it
was 28.5 ± 5.3 kg/m 2. The only demographic/cardiovascular
risk factor in which the difference between men and women
was significant was smoking history, where 23.5% of men had
a history of smoking while only 9.6% of females endorsed having a smoking history (P = 0.04). The differences between men
and women in terms of the other demographic data were not
significant (Table 1).
On comparison of all total vessel calcium scores (Table 2),
males had a higher total mean calcium score than females in
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each individual vessel. The results were as follows for males versus females, respectively: LM total vessel calcium score 46.49
versus 16.71 (P = 0.167); left anterior descending 265.21 versus
109.6 (P , 0.003); LCX 130.5 versus 39.7 (P , 0.004); right
coronary 213.5 versus 73.8 (P , 0.01). The odds of having a
total calcium score .100 (versus not) were 3.62 times greater in
males relative to females, given that all the other cardiovascular
risk factors are adjusted for (95% confidence interval [CI]:
1.37–9.54). On average, men had a mean of 2.1 ± 1.5 epicardial vessels with a calcium score $11 compared to 1.3 ± 1.4
for women (P , 0.005). Using a calcium score $101, men
had an average of 1.2 ± 1.4 epicardial vessels involved while
women had 0.67 ± 1.0 (P , 0.036).

Discussion

The marked gender differences in the presentation, diagnosis,
and management of cardiovascular disease have been established by numerous studies over the past half-century. 3–6 Premenopausal women in particular have significantly lower rates
of cardiovascular disease compared to age-matched males. The
explanation behind acknowledged differences between men
and women when it comes to cardiovascular disease remains
elusive, however. Numerous theories attempting to explain
these differences have been posited over the past 50 years. Nevertheless, no single unifying explanation can account for the
gender gap. The cause of these observed differences is likely an
amalgam of numerous variables, which have each been shown
to individually contribute to observed variations including differences in vascular beds, hormonal factors, as well as lifestyle
issues. Our study indicates that in addition to the differences
already described, there are stark dissimilarities between men
and women in the composition, distribution, and location of
intracoronary lesions which may explain some of the observed
variations in clinical presentation, sequelae, and outcomes.
The hormonal differences between males and females,
particularly premenopausal females who appear to have a
significant protective factor, have always been at the root of
comparisons in the rate of cardiovascular disease between
the genders. In the past five years, however, reports of the
Women’s Health Initiative and the Heart and Estrogen/
Progestin Replacement Study have indicated that combination
hormone therapy is actually associated with an increased risk of
Table 1. Baseline characteristics and cardiovascular disease risk
factors.
Males
(n = 85)

Females
(n = 53)

P value

Age (years)

60.0 ± 12.8

64.4 ± 10.8

0.05 (ns)

BMI (kg/m2)

29.5 ± 5.2

28.5 ± 5.3

0.26 (ns)

Hypertension

49 (57.6%)

33 (63.5%)

0.59 (ns)

Dyslipidemia

53 (62.4%)

33 (63.5%)

1.00 (ns)

Smoking history

20 (23.5)

5 (9.6)

0.04 (s)

CVD events in postmenopausal women, which seemed somewhat counterintuitive considering the theories that the female
hormones estrogen and progesterone were cardioprotective.7–10
These studies underscore the complicated nature of gender
difference and cardiovascular disease. Epidemiological data
indicate that compared with age-matched males, premenopausal females have a decreased incidence of virtually all types
of cardiovascular diseases, including coronary artery disease
(CAD), hypertension, and potentially harmful cardiac structural remodeling such as left ventricular hypertrophy. These
differences translate into a significant female advantage in
the rates of mortality from cardiovascular disease, with male
death rates from CHD ranging from 2.5 to 4.5 times that of
females across populations in different countries, with different lifestyles, and with variable population cardiovascular disease rates.11 The incidence of CHD in postmenopausal females
does increase significantly and in fact surpasses that of men as
demonstrated by the Framingham data.12,13
Gender dimorphism has been observed in nearly all
aspects of cardiovascular disease, from hypertension to cardiac remodeling to outcomes following percutaneous coronary
intervention for acute myocardial infarction. Animal models
have implicated a significant role for various estrogen receptors in the development of CHD and cardiac remodeling.14 In
addition, these hormones have even been implicated in rates of
hypertension. While sex hormones have been hypothesized to
contribute to the gender difference in blood pressure regulation,15 it is more likely that androgens and not estrogens are primarily responsible since androgens are known to increase blood
pressure, whereas studies on hormone replacement therapy
show essentially no effect on blood pressure in postmenopausal
women.16 Studies indicate that the increase in serum testosterone in postmenopausal women may result in increased risk
of hypertension and cardiovascular disease in these women.16
Table 2. Comparison of mean coronary artery calcium score based
upon gender.
Vessel

Males
(n = 85)

Females
(n = 53)

P value

LM

46.5 ± 142.9;
(0; 0–1,094)

16.7 ± 56.5;
(0; 0–358)

,0.167 (ns)

LAD

265.2 ± 395.2;
(88; 0–2,203)

109.56 ± 187.8;
(12; 0–989)

,0.003 (s)

LCX

130.5 ± 305.9;
(14; 0–1,993)

39.7 ± 115.6;
(0; 0–667)

,0.004 (s)

RCA

213.5 ± 364.9;
(14; 0–1,455)

73.79 ± 166.8;
(0; 0–806)

,0.010 (s)

Total vessel
calcium score

655.7 ± 1,037.5;
(154; 0–6,001)

239.71 ± 476.9;
(47.50; 0–2,820)

,0.003 (s)

Number of
vessels $11

2.1 ± 1.5;
(2; 0–4)

1.3 ± 1.4;
(1; 0–4)

,0.005 (s)

Number of
vessels .101

1.2 ± 1.4;
(1; 0–4)

0.67 ± 1.0;
(0; 0–4)

,0.036 (s)

Abbreviations: M, left main coronary artery; ns, nonsignificant; s, significant.
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Physiological changes associated with menopause affect several
biochemical pathways, including lipid metabolism, resulting
in a tendency toward elevated total cholesterol, triglycerides,
and low-density lipoprotein cholesterol.17,18 Postmenopausal
changes also result in enhanced activation of the coagulation
pathway with elevated serum levels of plasminogen activator
inhibitor-1 as well as fibrinogen.19,20 Further enhancing the
risk of cardiovascular disease in postmenopausal women is
impaired coronary artery vasoelasticity as well as increased
endothelial dysfunction.21 Thus, postmenopausal women have
numerous prothrombotic, atherogenic stimuli for the development of cardiovascular disease.
Prior to the recent development of noninvasive cardiac
imaging, it was difficult to characterize the nature of intracoronary arterial plaques. Using 64-CT coronary angiography allows characterization of the degree of calcification of
observed lesions and perhaps the likelihood of atherosclerotic plaque rupture and vascular stenosis potentially leading
to myocardial ischemia or infarction. The ability of CTA to
characterize atherosclerotic plaque burden has been shown to
be nearly as accurate as intravascular ultrasound.22,23 While
the main goal of CTA is not to identify potentially vulnerable plaques, lipid-laden plaques with the potential to rupture
can be a clinical guide as seen on CTA.24 CTA is capable
of detecting calcified or mixed plaques with sensitivities and
specificities of approximately 90%. The ability to detect lipidladen, noncalcified plaques is not as good, however, with sensitivities/specificities between 60% and 80%. 22,25
Our data indicate that men have a significantly higher average calcium score across all major coronary vessels, despite similarities in the age range and rate of the various major independent
cardiovascular disease risk factors. Even after adjusting for smoking (the only variable in which there was a statistically significant
difference), males were still 3.62 times more likely to have a total
vessel calcium score greater than 100 (95% CI: 1.37–9.54). In
addition to higher overall calcium scores, men also tended to
have a greater number of significant calcium scores (101–400),
indicating a high likelihood of a stenotic lesion. This may shed
light on the inconsistency that despite markedly higher calcium
scores in most coronary arteries, the rate of CHD between postmenopausal females and males of similar age are comparable
and even higher in women according to some data.
The differences demonstrated by our CT data indicate
that males have a higher incidence of significant plaque calcification possibly resulting in some degree of flow limitation
while females have significantly lower scores in each coronary
vessel except for the LM coronary artery (Figure 1). In the
LAD, LCX, and RCA, the males had a statistically significant
higher measured calcium score in each vessel. The fact that
postmenopausal women still have similar rates of CHD indicates that the plaques seen on CTA in women may in fact, be
more lipid-laden and therefore less stable than those observed
in males. As a result, the mechanisms resulting in the variety
of cardiovascular disease events such as stable/unstable angina
54
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and myocardial infarction may vary somewhat between males
and females. Acute coronary syndromes most often result from
disruption of intra-arterial coronary plaques resulting in thrombus formation, migration, and vessel occlusion. Large plaques
that limit coronary artery flow (particularly under stress) as
well as unstable, less calcified plaques have a greater likelihood
of rupture and thrombus formation. The implications of this
are significant for the utility of coronary CTA in predicting the
risk of cardiovascular disease events based solely upon calcium
scoring. The published data from the Multi-Ethnic Study of
Atherosclerosis trial demonstrated the significantly higher risk
of CAD events among patients with a calcium score between
1 and 10 compared to those with a calcium score of 0 (hazard
ration 3.23, 95% CI 1.17–8.95).26 Data from this large-scale
study also indicated that approximately 16% of coronary arteries
with significant stenosis on conventional invasive angiography
had no calcification on 64-CTA.27 The trend seen in this study
cohort of 6,110 individuals showed that men had higher calcium scores than women, and the amount and prevalence of calcium increased steadily with age. Almost two-thirds of women
(62%) had calcium scores of zero in this sample, as opposed
to 40% of men.26,27 While these findings show that calcification differences exist, further studies have demonstrated that
microvascular dysfunction gender variations exist28 and may
explain differences in outcome in stable patients and in patients
who present with acute coronary syndromes.29
According to our data, males have significantly larger, more
calcified plaques than females, who had smaller, significantly less
calcified lesions. The differences in plaque characteristics may
be a clue as to variations in the presentation of acute coronary
syndrome (ACS) in females compared to males. In addition, the
previously described factors used to explain gender differences in
cardiovascular disease such as hormonal variations, differences
in vascular beds, and lifestyle issues likely contribute to the differences observed in plaque characteristics. Given the differences
in observed plaque characteristics, more studies should be performed to analyze weather a different approach to medical therapy (such as more aggressive lipid-lowering therapy) in women
with suspected or proven cardiovascular disease is warranted.

Study Limitations

A drawback of our analysis is the selection bias of referring only low-risk patients to undergo coronary CTA and
referring higher risk patients directly to coronary angiography.
Although this may be a prudent means of evaluating and treating patients, it limits the assessment of the accuracy CTA for
the detection of CAD and introduces a select set of patients
for analysis which may lead to confounding factors. The present study was also limited to small numbers of patients in a
single center who underwent CTA and while the age of these
patients was known and can be surmised in many cases, the
menopausal status of the women was not available in this
study. Finally, all the baseline medications that each patient
was taking were not readily available, however, all these were
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64-CT image from a male with less
diffuse, more focal flow-limiting
calcification in the RCA.

64-CT image from a female with
diffuse, RCA calcification with no
significant flow-limiting lesions.

Figure 1. Comparison images of coronary plaque distribution between
males and females.

patients closely followed by their referring physicians and presumably taking their required medication regimen.

Conclusion

The observed differences between the sexes in cardiovascular
disease are likely the result of a variety of biologic/genetic, environmental, and behavioral factors. Noninvasive cardiac imaging can potentially shed light on these differences by describing
intra-arterial lesions both quantitatively and qualitatively. Our
study indicates that among males and females with comparable
age and presence of cardiovascular disease risk factors, males
tend to have significantly higher intra-arterial coronary calcium
scores than females in most coronary arteries. Since postmenopausal females have an equal if not higher risk of developing
cardiovascular disease as males, the mechanisms underlying the
development of angina and myocardial infarction, for example,
may, at least partially, be different according to gender. Differences in the composition of intra-arterial coronary lesions may
explain why men and women present with cardiovascular disease sequelae and why outcomes may vary according to gender.
More prospective studies correlating coronary plaque characte
ristics and long-term outcomes in patients deemed to be at risk
for coronary disease should be performed to optimize therapy
based upon all patient characteristics, including gender.
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